Results 161 to 170 of about 41,662 (194)

Laparoscopic cervical cerclage and pregnancy outcomes in consecutive pregnancies: An observational study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 3, Page 492-498, March 2026.
Laparoscopic cervical cerclage was associated with favorable neonatal outcomes in both first and subsequent pregnancies. Neonatal outcomes did not appear to differ based on whether the cerclage was placed pre‐ or postconception. High neonatal survival rates and favorable obstetric outcomes in both second and third pregnancies were demonstrated ...
Lise Qvirin Krogh, Lea Kirstine Hansen, Rikke Bek Helmig, Iben Sundtoft, Aiste Kloster, Axel Forman, Niels Ulbjerg, Julie Glavind   +7 more
wiley   +1 more source

Spontaneous duodenal perforation in a neonate: A case report. [PDF]

Radiol Case Rep
Semegn ZA, Kebede CL.
europepmc   +1 more source

Differences in prediction of adverse perinatal outcome in term pregnancies by choice of fetal growth reference: A validation study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 3, Page 466-478, March 2026.
In this study of 1 126 059 pregnancies, we find evidence of comparable predictive ability for adverse perinatal outcomes across four fetal growth references, but with notable differences in sensitivity and false positive rate (FPR). The WHO reference demonstrated balanced performance in detecting at‐risk fetuses, suggesting its suitability for clinical
Linda Lindström, Fredrik Ahlsson, Ove Axelsson, Michaela Granfors, Erik Lampa, Maria Nelander, Anna‐Karin Wikström   +6 more
wiley   +1 more source

Prevalence of neonatal necrotizing enterocolitis and predictors in Ethiopia: a systematic review and meta-analysis. [PDF]

Int Health
Balis B, Lami M, Musa I, Jibro U, Birhanu A, Yadeta TA.   +5 more
europepmc   +1 more source

Population‐Based Cohort Study for Development of National Retinopathy of Prematurity Screening Criteria

Acta Paediatrica, Volume 115, Issue 3, Page 671-678, March 2026.
ABSTRACT Aim Screening criteria for retinopathy of prematurity (ROP) vary among countries. Early detection of ROP and minimising the burden of screening are important. Methods We analysed data from very preterm infants born in Switzerland between 2006 and 2022.
R. Gerull, C. Sanchez, A. Atkinson, M. Schuler‐Barazzoni, M. Adams, F. Barcos Munoz, C. Gerth‐Kahlert, S. M. Schulzke, on behalf of the Swiss Neonatal Network, Ph. Meyer, L. Eisenhut, M. Bryant, A. Kidszun, T. Riedel, M. Gebauer, B. Rogdo, B. Wagner, R. E. Pfister, J.‐F. Tolsa, J. Schneider, M. Stocker, P. Gessler, B. Laubscher, J. Llor, A. Malzacher, A. Birkenmaier, L. Hegi, V. Bernet, M. Tomaske, D. Bassler, V. Cannizzaro, C. Hagmann   +31 more
wiley   +1 more source

Swiss Recommendations for the Perinatal Care of Extremely Low Gestational Age Neonates

Acta Paediatrica, Volume 115, Issue 3, Page 563-576, March 2026.
ABSTRACT Aim To revise the 2011 Swiss recommendations for the perinatal care of extremely low gestational age neonates (ELGANs). Methods Based on review of recent literature, experts from various medical specialties involved in the perinatal care of ELGANs made suggestions for revisions.
Thomas M. Berger, Markus Hodel, Giancarlo Natalucci, Mark Adams, Jean‐Claude Fauchère, on behalf of the Swiss Working Group on Perinatal Care of ELGANs, Mark Adams, Thomas M. Berger, Christine Diebold, Barbara Dinten, Jean‐Claude Fauchère, Deborah Gubler, Maya Hendriks, Markus Hodel, Christian Kind, Begoña Martinez de Tejada, Giancarlo Natalucci, Riccardo E. Pfister, Sven Schulzke, Daniel Surbek, Anita C. Truttmann   +20 more
wiley   +1 more source

SARS-CoV-2 infection during pregnancy and necrotizing enterocolitis: case report and review of the literature. [PDF]

Ital J Pediatr
Serra G, Pensabene M, Bacile D, Pace MRD, Ferraro D, Giuffrè M, Piro E, Salerno S, Schierz IAM, Sergio M, Corsello G.   +10 more
europepmc   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, Volume 183, Issue 6, Page 1271-1287, March 2026.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Correction: Characterization of gut microbiota signatures in Indian preterm infants with necrotizing enterocolitis: a shotgun metagenomic approach. [PDF]

Front Cell Infect Microbiol
Devarajalu P, Attri SV, Kumar J, Dutta S, Kabeerdoss J.   +4 more
europepmc   +1 more source